Medicines

Our Concerns Regarding Congressional Proposal to Discard Public Quality and Safety Standards for Biologics

Biologics Standards Proposal

For a hundred years, federal law has required that all drugs adhere to public quality standards—part of ensuring safety and protecting the public’s health. Language that would exempt biologics, including biosimilars, from adhering to the same public quality standards as other prescription medicines was recently added to the FDA and NIH Workforce Authorities Modernization Act. Learn about the potential impact this biologics quality exemption may have on competition, product development, and the public's confidence in biologics and biosimilars.

Share

A Multi-Sectorial Approach to Ensuring Medical Product Quality & Supply Chain Integrity

USP Contributes to APEC Initiative to Ensure Medical Product Quality & Supply Chain Integrity

Learn about USP's involvement in the APEC Life Sciences Innovation Forum and how this group is improving access to quality medical products by helping Asian-Pacific economies prevent, detect and respond to spurious, substandard, falsified, falsely-labelled and counterfeit products in their supply chains.

Share

Medication Safety 101: Join in Twitter Chat on Safe Usage, Storage and Disposal of OTCs

Twitter Chat for Patients on Medication Safety

Find out answers to important questions about your medications during a special live Twitter Chat “Medication Safety 101: Usage, Storage, and Disposal” on March 23. Hosted by the Alliance for Aging Research, in partnership with NCPIE, the Acetaminophen Awareness Coalition, the American Association of Poison Control Centers, and the CHPA Educational Foundation, this online discussion aims to answer common patient questions on how to safely choose, take, store, and dispose of OTC medications.  

Share

Pages